Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$810M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$745M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$671M |
| 4 |
Boeing
BA
|
+$390M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$784M |
| 2 |
NVIDIA
NVDA
|
+$532M |
| 3 |
Apple
AAPL
|
+$491M |
| 4 |
Amazon
AMZN
|
+$438M |
| 5 |
Newmont
NEM
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.71% |
| 2 | Financials | 11.26% |
| 3 | Healthcare | 8.31% |
| 4 | Industrials | 8.25% |
| 5 | Consumer Discretionary | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Consensus Cloud Solutions
CCSI
$670M
| $344K | ﹤0.01% |
14,418
+651
| +5% | +$15.3K |
|
3602
Leonardo DRS
DRS
$12.3B
| $344K | ﹤0.01% |
+10,642
| New | +$346K |
|
3603
Kymera Therapeutics
KYMR
$8.51B
| $344K | ﹤0.01% |
+8,544
| New | +$386K |
|
3604
iShares US Pharmaceuticals ETF
IHE
$1.46B
| $344K | ﹤0.01% |
5,230
+966
| +23% | +$66.5K |
|
3605
Camping World
CWH
$639M
| $343K | ﹤0.01% |
16,283
+7,473
| +85% | +$170K |
|
3606
Coca-Cola Femsa
KOF
$22.7B
| $343K | ﹤0.01% |
4,399
-265
| -6% | -$21.8K |
|
|
MQT
3607
DELISTED
BlackRock MuniYield Quality Fund II
MQT
| $343K | ﹤0.01% |
34,750
+3,000
| +9% | +$31.3K |
|
3608
Rezolute
RZLT
$454M
| $342K | ﹤0.01% |
+69,724
| New | +$351K |
|
3609
Revolve Group
RVLV
$1.8B
| $341K | ﹤0.01% |
10,190
+1,364
| +15% | +$42.3K |
|
3610
Denali Therapeutics
DNLI
$3.65B
| $341K | ﹤0.01% |
16,743
+9,343
| +126% | +$239K |
|
3611
Global X Emerging Markets Bond ETF
EMBD
$249M
| $341K | ﹤0.01% |
+15,094
| New | +$349K |
|
3612
Viemed Healthcare
VMD
$447M
| $340K | ﹤0.01% |
+42,418
| New | +$368K |
|
3613
Aurinia Pharmaceuticals
AUPH
$1.91B
| $339K | ﹤0.01% |
37,796
+26,981
| +249% | +$220K |
|
3614
FT Vest US Equity Buffer ETF January
FJAN
$1.43B
| $338K | ﹤0.01% |
+7,368
| New | +$334K |
|
|
ONC
3615
BeOne Medicines Ltd
ONC
$32.8B
| $337K | ﹤0.01% |
1,827
+8
| +0.4% | +$1.64K |
|
3616
iShares JPMorgan EM Corporate Bond ETF
CEMB
$398M
| $337K | ﹤0.01% |
7,587
+221
| +3% | +$9.96K |
|
3617
Ambarella
AMBA
$3.77B
| $336K | ﹤0.01% |
4,625
-38,556
| -89% | -$2.46M |
|
3618
SIGA Technologies
SIGA
$235M
| $335K | ﹤0.01% |
55,752
-8,897
| -14% | -$59.5K |
|
3619
Disc Medicine
IRON
$2.96B
| $335K | ﹤0.01% |
+5,278
| New | +$305K |
|
3620
VanEck Environmental Services ETF
EVX
$99.4M
| $334K | ﹤0.01% |
9,750
+50
| +0.5% | +$1.83K |
|
3621
Sutro Biopharma
STRO
$401M
| $332K | ﹤0.01% |
18,040
-183
| -1% | -$5.59K |
|
|
OPRA
3622
Opera Ltd
OPRA
$1.69B
| $331K | ﹤0.01% |
17,481
-21,188
| -55% | -$378K |
|
|
MREO
3623
Mereo BioPharma
MREO
$54.7M
| $331K | ﹤0.01% |
94,456
+61,642
| +188% | +$242K |
|
3624
United Microelectronic
UMC
$47.7B
| $328K | ﹤0.01% |
50,548
-27,847
| -36% | -$199K |
|
3625
Invesco DB Precious Metals Fund
DBP
$237M
| $326K | ﹤0.01% |
5,370
-2,104
| -28% | -$135K |
|
Similar funds
Ameriprise's Q4 2024 Portfolio in Review
As of Q4 2024, Ameriprise held 4,210 positions worth $390B, down 0.05% from $390B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Ameriprise's Q4 2024 filing shows 290 new, 1,777 increased, 1,865 reduced and 140 closed positions. Its largest new stake was Primo Brands: 2,607,261 shares worth $80.2M. The largest sale was Elevance Health, an estimated $784M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Ameriprise's largest Q4 2024 buy was Primo Brands: 2,607,261 shares worth $80.2M.
- Ameriprise added most to iShares Core US Aggregate Bond ETF in Q4 2024, an estimated $810M increase.
- Ameriprise's biggest Q4 2024 reduction was Elevance Health, cutting an estimated $784M.
- Ameriprise fully exited Primo Water Corporation in Q4 2024, selling an estimated $62.3M.
- Ameriprise's ten largest holdings make up 21% of its $390B portfolio in Q4 2024.
- Ameriprise opened 290 new positions and closed 140 in Q4 2024.
- Ameriprise's portfolio value fell 0.05% quarter-over-quarter to $390B.
Based on Ameriprise's 13F filing for Q4 2024, filed 14 Feb 2025.